Dr. Amaria is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
1515 Holcombe Blvd
Houston, TX 77030Phone+1 713-792-6161- Is this information wrong?
Education & Training
University of ColoradoFellowship, Hematology and Medical Oncology, 2010 - 2013- University of ColoradoResidency, Internal Medicine, 2006 - 2009
- University of Colorado School of Medicine Anschutz Medical CampusClass of 2006
Certifications & Licensure
FL State Medical License 2021 - Present
AZ State Medical License 2023 - 2026
TX State Medical License 2013 - 2025
TN State Medical License 2023 - 2025
GA State Medical License 2023 - 2025
LA State Medical License 2023 - 2024
OK State Medical License 2020 - 2024- American Board of Internal Medicine Medical Oncology
- Join now to see all
Clinical Trials
- Neoadjuvant and Adjuvant Checkpoint Blockade Start of enrollment: 2016 Feb 02
- Dabrafenib and Trametinib Before and After Surgery in Treating Patients With Stage IIIB-C Melanoma With BRAF V600 Mutation Start of enrollment: 2014 Oct 22
Roles: Contact, Principal Investigator
- Phase I, Open-Label, Study of Tumor Infiltrating Lymphocytes Engineered With Membrane Bound IL15 Plus Acetazolamide in Adult Patients With Metastatic Melanoma Start of enrollment: 2022 Sep 07
Roles: Contact, Principal Investigator
- Join now to see all
Publications & Presentations
PubMed
- Expert consensus guidelines on management and best practices for tumor-infiltrating lymphocyte cell therapy.Allison Betof Warner, Omid Hamid, Krishna Komanduri, Rodabe Amaria, Marcus O Butler, John Haanen, Sarah Nikiforow, Igor Puzanov, Amod Sarnaik, Michael R Bishop, Adam J...> ;Journal for Immunotherapy of Cancer. 2024 Feb 29
- Efficacy and safety of autologous tumor-infiltrating lymphocytes in recurrent or refractory ovarian cancer, colorectal cancer, and pancreatic ductal adenocarcinoma.Amaria, R., Knisely, A., Vining, D., Kopetz, S., Overman, M., Javle, M., Antonoff, M., Tzeng, C., Wolff, R., Pant, S., Lito, K., Rangel, K., Fellman, B., Yuan, Y., Lu,...> ;Journal for Immunotherapy of Cancer. 2024 Feb 2
- 10 citationsNeoadjuvant immunotherapy for melanoma is now ready for clinical practice.Claus Garbe, Reinhard Dummer, Teresa Amaral, Rodabe N Amaria, Paolo A Ascierto, Elizabeth M Burton, Brigitte Dreno, Alexander M M Eggermont, Axel Hauschild, Christoph ...> ;Nature Medicine. 2023 Jun 1
- Join now to see all
Press Mentions
Breakthrough Study Shows Promise for mRNA Cancer VaccinesApril 17th, 2023- In What Could Be a 'Big Shift' for Cancer Treatment, mRNA Vaccine Shows Promise Against MelanomaApril 16th, 2023
- FDA Gives MD Anderson the Green Light to Test Skin Cancer Treatment on HumansAugust 16th, 2022
- Join now to see all
Hospital Affiliations
University of Texas M.D. Anderson Cancer CenterHouston, Texas
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
